Embera NeuroTherapeutics, Inc. To Receive Grant For Clinical Trial Through New Crowd Funding Platform
7/1/2014 11:19:54 AM
BOSTON & SHREVEPORT, La.--(BUSINESS WIRE)--Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for smoking cessation and other addictions, today announced that Sound Affects Life, a 501(c)3 not-for-profit charity, has selected Embera as part of its inaugural group of companies to receive a grant funded by contributions through Soundaffectslife.org. Soundaffectslife.org, which launches today, is a new crowd funding platform designed to connect individuals with organizations that are actively seeking improved outcomes in cancer. The grant will support the evaluation of EMB-001, the company’s lead drug candidate, in a Phase 1 clinical trial enrolling individuals who smoke but are otherwise healthy.
Help employers find you! Check out all the jobs and post your resume.
comments powered by